Movatterモバイル変換

[0]ホーム
URL:

WO2009074328A8 - Methods and nucleic acids for analyses of lung carcinoma - Google Patents

Methods and nucleic acids for analyses of lung carcinomaDownload PDF

Info

Publication number
WO2009074328A8
WO2009074328A8PCT/EP2008/010549EP2008010549WWO2009074328A8WO 2009074328 A8WO2009074328 A8WO 2009074328A8EP 2008010549 WEP2008010549 WEP 2008010549WWO 2009074328 A8WO2009074328 A8WO 2009074328A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
lung carcinoma
analyses
methods
improved
Prior art date
Application number
PCT/EP2008/010549
Other languages
French (fr)
Other versions
WO2009074328A2 (en
WO2009074328A3 (en
Inventor
Dimo Dietrich
Volker Liebenberg
Reimo Tetzner
Jürgen Distler
Jörn LEWIN
Thomas Schlegel
Original Assignee
Epigenomics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AgfiledCriticalEpigenomics Ag
Priority to EP08860719ApriorityCriticalpatent/EP2229456A2/en
Priority to CA2708163Aprioritypatent/CA2708163A1/en
Priority to JP2010537317Aprioritypatent/JP5694776B2/en
Priority to US12/747,584prioritypatent/US20110003292A1/en
Priority to AU2008334901Aprioritypatent/AU2008334901A1/en
Publication of WO2009074328A2publicationCriticalpatent/WO2009074328A2/en
Publication of WO2009074328A3publicationCriticalpatent/WO2009074328A3/en
Publication of WO2009074328A8publicationCriticalpatent/WO2009074328A8/en
Priority to US14/978,642prioritypatent/US20160194722A1/en
Priority to US15/672,858prioritypatent/US20180023144A1/en

Links

Classifications

Landscapes

Abstract

The invention provides methods, nucleic acids and kits for detecting lung carcinoma. The invention discloses genomic ( F0XL2, ONECUTl, TFAP2E, EN2-2, EN2-3, SH0X2-2 and BARHL2) sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients.
PCT/EP2008/0105492007-12-112008-12-11Methods and nucleic acids for analyses of lung carcinomaWO2009074328A2 (en)

Priority Applications (7)

Application NumberPriority DateFiling DateTitle
EP08860719AEP2229456A2 (en)2007-12-112008-12-11Methods and nucleic acids for analyses of cell proliferative disorders
CA2708163ACA2708163A1 (en)2007-12-112008-12-11Methods and nucleic acids for analyses of cell proliferative disorders
JP2010537317AJP5694776B2 (en)2007-12-112008-12-11 Methods and nucleic acids for analysis of cell proliferative disorders
US12/747,584US20110003292A1 (en)2007-12-112008-12-11Methods and nucleic acids for analyses of cell proliferative disorders
AU2008334901AAU2008334901A1 (en)2007-12-112008-12-11Methods and nucleic acids for analyses of lung carcinoma
US14/978,642US20160194722A1 (en)2007-12-112015-12-22Methods and nucleic acids for analyses of cell proliferative disorders
US15/672,858US20180023144A1 (en)2007-12-112017-08-09Methods and nucleic acids for analyses of cell proliferative disorders

Applications Claiming Priority (4)

Application NumberPriority DateFiling DateTitle
EP07122844.92007-12-11
EP071228442007-12-11
EP081505572008-01-23
EP08150557.02008-01-23

Related Child Applications (2)

Application NumberTitlePriority DateFiling Date
US12/747,584A-371-Of-InternationalUS20110003292A1 (en)2007-12-112008-12-11Methods and nucleic acids for analyses of cell proliferative disorders
US14/978,642DivisionUS20160194722A1 (en)2007-12-112015-12-22Methods and nucleic acids for analyses of cell proliferative disorders

Publications (3)

Publication NumberPublication Date
WO2009074328A2 WO2009074328A2 (en)2009-06-18
WO2009074328A3 WO2009074328A3 (en)2009-08-13
WO2009074328A8true WO2009074328A8 (en)2009-12-03

Family

ID=40362005

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/EP2008/010549WO2009074328A2 (en)2007-12-112008-12-11Methods and nucleic acids for analyses of lung carcinoma

Country Status (6)

CountryLink
US (3)US20110003292A1 (en)
EP (2)EP2302069A1 (en)
JP (1)JP5694776B2 (en)
AU (1)AU2008334901A1 (en)
CA (1)CA2708163A1 (en)
WO (1)WO2009074328A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20110171637A1 (en)*2006-07-212011-07-14Reimo TetznerMethods and nucleic acids for analyses of cellular proliferative disorders
EP2099938B1 (en)2006-11-242016-11-16Epigenomics AGMethods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
GB0823445D0 (en)*2008-12-232009-01-28Univ SurreyBiomarker
GB0912190D0 (en)*2009-07-132009-08-26Univ SurreyBiomarker
GB0912175D0 (en)*2009-07-132009-08-26Univ SurreyBiomarker
US20120157324A1 (en)*2009-08-172012-06-21Yale UniversityMethylation biomarkers and methods of use
US20110104695A1 (en)*2009-11-052011-05-05Epigenomics AgMethods of predicting therapeutic efficacy of cancer therapy
CA3111723A1 (en)*2012-01-302013-08-08Exact Sciences Development Company, LlcSulfonated small dna compositions and methods for sulfonating and desulfonating small dnas
EP2914753A4 (en)*2012-10-312016-06-08Becton Dickinson CoSelective amplification and real-time pcr detection of rare mutations
JP2014161308A (en)*2013-02-272014-09-08St Marianna Univ School Of MedicineMethod for obtaining the index of detection of gastric cancer or risk assessment of gastric cancer onset
AU2017260630B2 (en)*2016-05-052023-07-13Exact Sciences CorporationDetection of lung neoplasia by analysis of methylated DNA
EP3963096A4 (en)*2019-05-292023-01-25HKG Epitherapeutics Limited EPIAGING: NOVEL ECOSYSTEM FOR MANAGING HEALTHY AGING

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5585481A (en)1987-09-211996-12-17Gen-Probe IncorporatedLinking reagents for nucleotide probes
US5457183A (en)1989-03-061995-10-10Board Of Regents, The University Of Texas SystemHydroxylated texaphyrins
US5245022A (en)1990-08-031993-09-14Sterling Drug, Inc.Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en)1992-01-211996-10-15Pharmacyclics, Inc.Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en)1992-12-151996-11-12Microprobe CorporationPeptide linkers for improved oligonucleotide delivery
SE501439C2 (en)1993-06-221995-02-13Pharmacia Lkb Biotech Method and apparatus for analyzing polynucleotide sequences
DE69417918T2 (en)1993-11-302000-01-05Mcgill University, Montreal DNA METHYL TRANSFERASE INHIBITION
US5597696A (en)1994-07-181997-01-28Becton Dickinson And CompanyCovalent cyanine dye oligonucleotide conjugates
US5514758A (en)1994-09-301996-05-07The Goodyear Tire & Rubber CompanyProcess for making latex for high performance masking tape
US6017704A (en)1996-06-032000-01-25The Johns Hopkins University School Of MedicineMethod of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en)1996-06-031998-07-28The Johns Hopkins University School Of MedicineMethod of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5912264A (en)1997-03-031999-06-15Bristol-Myers Squibb Company6-halo-or nitrate-substituted paclitaxels
US6251594B1 (en)1997-06-092001-06-26Usc/Norris Comprehensive Cancer Ctr.Cancer diagnostic method based upon DNA methylation differences
DE19754482A1 (en)1997-11-271999-07-01Epigenomics Gmbh Process for making complex DNA methylation fingerprints
US7700324B1 (en)1998-11-032010-04-20The Johns Hopkins University School Of MedicineMethylated CpG island amplification (MCA)
US5958773A (en)1998-12-171999-09-28Isis Pharmaceuticals Inc.Antisense modulation of AKT-1 expression
US6331393B1 (en)1999-05-142001-12-18University Of Southern CaliforniaProcess for high-throughput DNA methylation analysis
AU2002212187A1 (en)*2000-09-012002-03-13Epigenomics AgDiagnosis of illnesses or predisposition to certain illnesses
US20050235375A1 (en)*2001-06-222005-10-20Wenqiong ChenTranscription factors of cereals
US7473767B2 (en)2001-07-032009-01-06The Institute For Systems BiologyMethods for detection and quantification of analytes in complex mixtures
DE10338308B4 (en)2003-08-152006-10-19Epigenomics Ag Method for the detection of cytosine methylations in DNA
EP2302073A1 (en)*2004-07-182011-03-30Epigenomics AGEpigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
WO2006060653A2 (en)*2004-11-302006-06-08Veridex LlcLung cancer prognostics
ES2331146T3 (en)*2004-12-022009-12-22Epigenomics Ag PROCEDURES AND NUCLEIC ACIDS FOR THE ANALYSIS OF GENETIC EXPRESSION ASSOCIATED WITH THE FORECAST OF PROLIFERATIVE DISORDERS OF PROSTATIC CELLS.
ES2533767T3 (en)*2005-04-152015-04-15Epigenomics Ag Methods for the analysis of cell proliferative disorders
EP1885919B1 (en)*2005-05-272013-02-13Dana-Farber Cancer Institute, Inc.Gene methylation and expression
EP1991274A4 (en)*2006-01-202009-06-10Women S And Children S Health METHOD FOR THE TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BONE DISEASES
WO2007085497A2 (en)*2006-01-302007-08-02Epigenomics AgMarkers for the prediction of outcome of anthracycline treatment
DK1826279T3 (en)*2006-02-282011-09-05Charite Universitaetsmedizin Detection and quality control of regulatory t cells by DNA methylation analysis of the FoxP3 gene
EP2046994A4 (en)*2006-07-142010-04-14Univ Johns Hopkins Early detection and prognosis of colon cancer
US20090203011A1 (en)*2007-01-192009-08-13Epigenomics AgMethods and nucleic acids for analyses of cell proliferative disorders
SI2258871T1 (en)*2007-01-192014-09-30Epigenomics Ag Intellectual PropertyMethods and nucleic acids for analyses of cell proliferative disorders
CN101688239A (en)*2007-02-122010-03-31约翰·霍普金斯大学 Colon Cancer Early Detection and Prognosis
JP2008212009A (en)*2007-02-282008-09-18Sysmex CorpMethod for preparing sample for detecting dna methylation
US20130007927A1 (en)*2010-01-222013-01-03Chromatin, Inc.Novel centromeres and methods of using the same

Also Published As

Publication numberPublication date
CA2708163A1 (en)2009-06-18
US20110003292A1 (en)2011-01-06
JP5694776B2 (en)2015-04-01
US20160194722A1 (en)2016-07-07
JP2011505812A (en)2011-03-03
US20180023144A1 (en)2018-01-25
AU2008334901A1 (en)2009-06-18
WO2009074328A2 (en)2009-06-18
WO2009074328A3 (en)2009-08-13
EP2302069A1 (en)2011-03-30
EP2229456A2 (en)2010-09-22

Similar Documents

PublicationPublication DateTitle
WO2009074328A8 (en)Methods and nucleic acids for analyses of lung carcinoma
WO2008087040A3 (en)Methods and nucleic acids for analyses of cell proliferative disorders
CA2840149C (en)Methods and nucleic acids for determining the prognosis of a cancer subject
WO2006113466A3 (en)Methods and nucleic acids for analyses of cellular proliferative disorders
WO2007118704A3 (en)Methods and nucleic acids for the detection of colorectal cell proliferative disorders
WO2008134596A3 (en)Use of methylated or unmethylated line-i dna as a cancer marker
WO2008039769A3 (en)Methods and devices for analyzing small rna molecules
WO2009015863A3 (en)Methods of detecting methylated dna at a specific locus
WO2007081720A3 (en)Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
WO2010017515A3 (en)Breast cancer specific markers and methods of use
WO2009153775A3 (en)Methods for distinguishing between specific types of lung cancers
WO2007143037A3 (en)Gene methylation in cancer diagnosis
ZA200808669B (en)Methods of treating, diagnosing or detecting cancer
WO2010007083A3 (en)Methods and nucleic acids for analyses of cell proliferative disorders
WO2005001141A8 (en)Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO2006081248A3 (en)Cancer markers and detection methods
WO2008008983A3 (en)Methods and nucleic acids for analyses of cellular proliferative disorders
WO2006034879A3 (en)Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders
WO2008104985A3 (en)Methods for distingushing between lung squamous carcinoma and other non smallcell lung cancers
WO2007115213A3 (en)Methods and nucleic acids for analyses of cellular proliferative disorders
WO2005001140A3 (en)Methods and nucleic acids for the analysis of colon cell proliferative disorders
WO2010017461A3 (en)Gene methylation in cancer diagnosis
WO2008049022A3 (en)Methods for detection of cancer
WO2011010870A3 (en)Genetic marker for predicting the survival of a patient with early-stage lung cancer, and method for predicting survival using same
HK1116199A (en)Methods of treating, diagnosing or detecting cancer

Legal Events

DateCodeTitleDescription
121Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number:08860719

Country of ref document:EP

Kind code of ref document:A2

WWEWipo information: entry into national phase

Ref document number:2708163

Country of ref document:CA

WWEWipo information: entry into national phase

Ref document number:2010537317

Country of ref document:JP

NENPNon-entry into the national phase

Ref country code:DE

ENPEntry into the national phase

Ref document number:2008334901

Country of ref document:AU

Date of ref document:20081211

Kind code of ref document:A

WWEWipo information: entry into national phase

Ref document number:2008860719

Country of ref document:EP

WWEWipo information: entry into national phase

Ref document number:12747584

Country of ref document:US
[8]ページ先頭
©2009-2025 Movatter.jp